SecBot SecBot
SECBOTREPLAY Home › Report › SANA

SANA · Sana Biotechnology entered into a stock purchase agreement with Mayo…

Sana Biotechnology, Inc. · 8-K filed Apr 13, 2026 at 16:10 ET

At the news

BULLISHIMPACT 6/10

8-K filed Apr 13, 2026 at 16:10 ET

Sana Biotechnology entered into a stock purchase agreement with Mayo Clinic, selling 7.5 million shares for $25 million upfront, with an option for Mayo Clinic to purchase an additional 7.5 million shares for another $25 million. The proceeds will be used for developing diabetes therapies, and Mayo Clinic agreed to a six-month lock-up period.

  • Sana Biotechnology sold 7,507,507 shares to Mayo Clinic for $24.999 million at $3.33 per share
  • Mayo Clinic has the option to purchase an additional 7,507,507 shares for $24.999 million
  • Proceeds will be used for developing products including SC451 and genetically modified stem-cell derived islet cell products
  • Mayo Clinic agreed to a lock-up period of six months from the initial closing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access